SCHEMBL6983056

SCHEMBL6983056

CCOC(=O)CC1(CCl)OCCO1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.39
MGAM O43451 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.37
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 8/20 0.36
TRPA1 O75762 1/20 0.36
LMNA P02545 3/20 0.36
TSHR P16473 2/20 0.36
POLB P06746 2/20 0.36
HSD17B10 Q99714 2/20 0.35
CTDSP1 Q9GZU7 1/20 0.35
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HTT P42858 1/20 0.33
CYP1A2 P05177 1/20 0.32
ATM Q13315 1/20 0.32
MEN1 O00255 1/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16204253 0.89 GAA (0.44) GAAMGAMSIMGAM2L3MBTL1
SCHEMBL10207770 0.85 GAA (0.41) GAAMGAMSIMGAM2L3MBTL1
SCHEMBL10207669 0.82 GAA (0.39) GAAMGAMSIMGAM2L3MBTL1
SCHEMBL16948227 0.81 GAA (0.38) GAAMGAMSIMGAM2L3MBTL1
SCHEMBL16946140 0.81 GAA (0.38) GAAMGAMSIMGAM2L3MBTL1
SCHEMBL18233777 0.79 ALDH1A1 (0.39) GAAMGAMSIMGAM2L3MBTL1
SCHEMBL13124943 0.78 GAA (0.36) GAAMGAMSIMGAM2L3MBTL1
SCHEMBL12513908 0.78 GAA (0.34) GAAMGAMSIMGAM2L3MBTL1
SCHEMBL10373036 0.77 GAA (0.36) GAAMGAMSIMGAM2L3MBTL1
SCHEMBL4350073 0.77 PRKCA (0.38) GAAL3MBTL1KMT2ALMNAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102875602-A Preparation method of minodronate hydrate JIANGSU SHENLONG PHARMACEUTICAL CO LTD 2013-01-16 CN disclosed
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0481429-B1 Quinoline derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
EP-0987262-A1 Quinoline derivatives SS PHARMACEUTICAL CO., LTD. (JP) 2000-03-22 EP disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed
US-5300517-A Treating Alzheimer's SS PHARMACEUTICAL CO., LTD. (JP) 1994-04-05 US disclosed
US-5240934-A Cognition activators SS PHARMACEUTICAL CO., LTD. (JP) 1993-08-31 US disclosed
US-5190951-A Inhibitors of acetylcholinesterase, treatment of senile dementia SS PHARMACEUTICAL CO., LTD. (JP) 1993-03-02 US disclosed
EP-0481429-A2 Quinoline derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1992-04-22 EP disclosed